|

Yangxinshi tablet Clinical Trials

1 actively recruiting trial

Also known as: Yangxinshi

Pipeline

Phase 4: 1

Top Sponsors

  • SPH Qingdao Growful Pharmacetical Co.,Ltd1

Indications

  • Cardiac Dysfunction1
  • Coronary Heart Disease1
  • Heart Disease1

Other1 trial

Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.